Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

119,122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A mouse model of conditional lipodystrophy.
Kim S, Huang LW, Snow KJ, Ablamunits V, Hasham MG, Young TH, Paulk AC, Richardson JE, Affourtit JP, Shalom-Barak T, Bult CJ, Barak Y. Kim S, et al. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16627-32. doi: 10.1073/pnas.0707797104. Epub 2007 Oct 5. Proc Natl Acad Sci U S A. 2007. PMID: 17921248 Free PMC article.
Ligand-Dependent Corepressor (LCoR) Is a Rexinoid-Inhibited Peroxisome Proliferator-Activated Receptor γ-Retinoid X Receptor α Coactivator.
Shalom-Barak T, Liersemann J, Memari B, Flechner L, Devor CE, Bernardo TM, Kim S, Matsumoto N, Friedman SL, Evans RM, White JH, Barak Y. Shalom-Barak T, et al. Among authors: kim s. Mol Cell Biol. 2018 Apr 16;38(9):e00107-17. doi: 10.1128/MCB.00107-17. Print 2018 May 1. Mol Cell Biol. 2018. PMID: 29463649 Free PMC article.
Esrrb-Cre excises loxP-flanked alleles in early four-cell embryos.
Lee S, Pallerla SR, Kim S, Shaffer B, Simerly CR, Richard Chaillet J, Barak Y. Lee S, et al. Among authors: kim s. Genesis. 2016 Jan;54(1):53-61. doi: 10.1002/dvg.22912. Epub 2015 Dec 28. Genesis. 2016. PMID: 26663459 Free PMC article.
3-Fucosyllactose-Mediated Modulation of Immune Response against Virus Infection.
Moon S, Lee KW, Park M, Moon J, Park SH, Kim S, Hwang J, Yoon JW, Jeon SM, Kim JS, Jeon YJ, Kweon DH. Moon S, et al. Among authors: kim s. Int J Antimicrob Agents. 2024 Apr 30:107187. doi: 10.1016/j.ijantimicag.2024.107187. Online ahead of print. Int J Antimicrob Agents. 2024. PMID: 38697577 No abstract available.
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): patient-reported outcomes from a randomised, open-label, multicentre, phase 3 trial.
Fehm T, Cottone F, Dunton K, André F, Krop I, Park YH, De Laurentiis M, Miyoshi Y, Armstrong A, Borrego MR, Yerushalmi R, Duhoux FP, Takano T, Lu W, Egorov A, Kim SB. Fehm T, et al. Among authors: kim sb. Lancet Oncol. 2024 May;25(5):614-625. doi: 10.1016/S1470-2045(24)00128-1. Lancet Oncol. 2024. PMID: 38697155 Clinical Trial.
119,122 results
You have reached the last available page of results. Please see the User Guide for more information.